Moreover, Lan et al. [17] reported that the overexpression of TOP2A significantly correlated with more advanced American Joint of Cancer Committee (AJCC) stages and independently predicted worse disease-specific survival (DSS) and distant metastasis-free survival (DMFS) in nasopharyngeal carcinoma. This evidence concerns the gene TOP2A and nasopharyngeal carcinoma.